News
When volunteering pays off ...
Schwabe supports the voluntary commitment of its employees: In autumn 2025, six Schwabe employees each received a Community Grant of €1,000 for the projects in which they are involved.
Teamwork for a cleaner future
23 colleagues at Schwabe headquarters in Germany came together in October 2025, for our annual Cleanup Day. Equipped with safety vests, grabbers, and trash bags, we collected everything from cigarette butts and packaging waste to the usual litter that harms our environment.
Cognitive Health: EGb 761® Study Reveals Bioactive Role of Proanthocyanidins
We’re excited to share our latest research published in Frontiers in Pharmacology – Ethnopharmacology exploring a previously underappreciated component of Ginkgo biloba—proanthocyanidins (PACs)—and their contribution to cognitive health. Our study sheds light on their antioxidative potency, bioavailability, and antiamnesic effects.
2nd Focus Day on sustainability for Schwabe trainees
Beim 2. Azubi-Aktionstag der Schwabe-Gruppe zum Thema Nachhaltigkeit kamen Azubis und duale Studierende aller Lehrjahre und Berufsbilder zusammen, um gemeinsam für mehr Artenvielfalt zu sorgen.
Impact that lasts: The Umckaloabo Foundation creates perspectives through education
Since its founding by the Schwabe Group in 2010, the Umckaloabo Foundation has been committed to improving educational opportunities in Southern Africa. Over the past 15 years, the Foundation has invested more than €7 million, giving over 50,000 children access to education.
Dr. Willmar Schwabe Young Talent Prize Awarded to Dr. Maria-Eleni Grafakou
We are pleased to announce that the Dr. Willmar Schwabe Young Talent Prize 2025 has been awarded to Dr. Maria-Eleni Grafakou. Dr. Grafakou is being recognized for her outstanding contributions to translational research in the field of herbal medicines and the gut-brain axis.
Schwabe Group's Energy Management Reaches Milestone
The Schwabe Group has successfully certified its energy management system according to DIN EN ISO 50001 for all locations in Germany. This certification marks a significant milestone in our sustainability and energy efficiency efforts. It confirms the quality of our processes while also committing us to continuously improve our energy performance.
Successful kick-off for large clinical study with EGb 761® in China
We are pleased to announce that, under the scientific direction of the renowned researcher Prof. Yongjun Wang, we have successfully kicked-off a large clinical trial with EGb 761® in patients with cognitive impairment after stroke in China (GiCIIS - Ginkgo Biloba in Cognitive Impairment after an acute Ischemic Stroke).
Schwabe Supports International Congress on Medicinal Plant and Natural Product Research as Gold Sponsor
The Schwabe Group together with Bayer and the Euromed Group has become the top sponsor of the 73rd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA). The congress will take place from August 31 to September 3, 2025 in Naples, Italy.
14.02.2023 - A clinical trial assessed the use of EPs® 7630 as Syrup and Solution in children ages one to five with acute bronchitis. The study found that an improvement in health status and complaints were comparably positive in treatment with EPs® 7630. Both dosage forms were equally safe and well-tolerated in children between the ages of one and five.
26.01.2023 - In 2022, the Schwabe Group Germany converted to green electricity at both of its sites in Karlsruhe. This means that all of the electricity obtained from our power supplier comes from renewable kinds of energy.
15.01.2023 - We are pleased to announce a new research agreement with Dalhousie University from Nova Scotia, Canada. In conjunction with Prof. Vasantha Rupasinghe, one of the leading experts in the field of research about the haskap berry, we will analyze novel extraction methods for producing a special extract with enriched active substances (cyanidin-3-glucoside).
05.12.2022 - We are pleased to announce that our high-quality pharmaceutical Refluthin® was launched in Belgium. New Refluthin® chewable tablets have twice the effect on heartburn: the mineral-based acid buffers quickly soothe acid-related gastric discomfort such as heartburn and acid regurgitation.
21.11.2022 - Our Web Content Management System (WCMS) is one of the winners of this year's SplashAwards. In the category "Healthcare", the Schwabe Group came out as the best Drupal project..
16.11.2022 - Schwabe Group Germany received an award this year once again for its commitment to offering professional training! The business magazine Capital gave us full marks in the fields of mentorship, innovative teaching methods, and excellent future prospects!
13.10.2022 - For over 10 years Nature’s Way has been quietly supporting Feed the Children – a non-profit organization which envisions a world in which no child goes to bed hungry.
16.09.202 - The Dr Willmar Schwabe Award, which is sponsored by our company, was first presented by the GA – Society for Medicinal Plant and Natural Product Research, one of the world’s most important scientific societies in phytoresearch, back in 1961. This year Dr Simone Moser from Ludwig Maximilian University of Munich, was awarded for her innovative and pioneering research.
14.09.2022 - At the 39th Annual Healthcare Advertising Award ceremony, Schwabe’s explainer video on the topic of mild cognitive impairment (MCI) won over the jury and brought home a Merit Award.
25.08.2022 - The Pegaso® line consists of probiotics, prebiotics, herbal ingredients and vitamins, and it represents a distinctive therapeutic approach to specific GI complaints (diarrhea, constipation, etc.). At the same time, it is ideal for treating a variety of problems in children and adults.
29.07.2022 - In a recent review, Bartova et al.* present findings that Silexan® has beneficial effects also on co-occurring depressive symptoms in patients with underlying anxiety and anxiety disorders. The data were collected from patients with anxiety in several clinical trials and have now been recompiled and statistically analyzed.
08.06.2022 - As part of the Schwabe Phyto Innovation Challenge, we are pleased to announce a new research agreement with the department of pharmacognosy at the University of Vienna. Under the guidance of chair Dr. Judith M. Rollinger, we will spend the next three years working on a joint project to analyze the positive effects of herbal extracts and combinations of natural substances on age-related diseases.
07.07.2022 - As part of the Schwabe Phyto Innovation Challenge, we have now successfully launched a collaborative project: Dr. Simone Moser and her team will analyze phylloxanthobilins; this group of substances was discovered in recent years and is thought to have potentially positive effects on arteriosclerosis. The process of the blood vessels hardening is responsible for the majority of cardiovascular problems in older people.
13.04.2022 - We are pleased to announce that our high-quality pharmaceutical Gaspan® was launched in Italy. Recurrent or persistent gastrointestinal complaints such as flatulence, mild cramps and a feeling of fullness impair quality of life. Gaspan® works with a unique combination of peppermint oil and caraway oil and has a targeted effect where the discomfort is caused: in the gut.